Aytu BioPharma Inc AYTU
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $2.09
- Day Range
- $2.08–2.08
- 52-Week Range
- $1.80–3.00
- Bid/Ask
- $2.05 / $2.15
- Shares Outstanding
- 10.87M
- Market Cap
- $22.71M
- Volume/Avg
- 738 / 34,623
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.45
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 76
- Website
- https://www.aytubio.com
Valuation
|
Metric
|
AYTU
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.63 |
Price/Sales | 0.45 |
Price/Cash Flow | — |
Price/Earnings
AYTU
Financial Strength
|
Metric
|
AYTU
|
|---|---|
Quick Ratio | 0.90 |
Current Ratio | 1.13 |
Interest Coverage | −6.51 |
Quick Ratio
AYTU
Profitability
|
Metric
|
AYTU
|
|---|---|
Return on Assets (Normalized) | −7.01% |
Return on Equity (Normalized) | −32.50% |
Return on Invested Capital (Normalized) | −14.31% |
Return on Assets
AYTU
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|!&?@@$& | LOCK|lc>J@ | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|#!KXB>%& | LOCK|cv<@B | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|$D^?C> | LOCK|hT | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|^s?Z?c& | LOCK|@w | $29B | |||
| Viatris Inc
VTRS
| LOCK|!v%BJ& | LOCK|g? | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|!l | LOCK|!n | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|dh#jpdP | LOCK|TQ | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$^%nl% | LOCK|Tb | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|Mm??b& | LOCK|GGbv& | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|HTSgpc | LOCK|kv | $2B |
United States